JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2019. Vol. 64. No. 2. P. 70–74
DOI: 10.12737/article_5ca607bf670c97.49055999
K.E. Medvedeva, I.A. Gulidov, Yu.S. Mardynski, D.V. Gogolin, K.B. Gordon, A.V. Semenov, O.G. Lepilina, A.D. Kaprin, А.А. Kostin, S.A. Ivanov
Proton Therapy for Re-Irradiation of Recurrent Gliomas
A.F. Tsyb Medical Radiological Research Center, Obninsk, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
K.E. Medvedeva – Junior Researcher;
I.A.Gulidov – Head of Dep., Dr. Sci. Med., Prof.;
Yu.S. Mardynski – Chef Researcher, Corr. Member RAS, Dr. Sci. Med., Prof.;
D.V. Gogolin – Senior Researcher, PhD Med.;
K.B. Gordon – Researcher at the West German Proton Therapy Center, (Essen, Germany), PhD Med.;
A.V. Semenov – Junior Researcher; O.G. Lepilina – Research Assistant;
A.D. Kaprin – Director General, Academic RAS, Dr. Sci. Med., Prof.;
A.A. Kostin – First Deputy of Director General, Dr. Sci. Med., Prof. RAS;
S.A. Ivanov – Director, Dr. Sci. Med., Prof. RAS
Abstract
Purpose: To define efficiency and safety of use of the active scanning proton beam in reirradiation of recurrent malignant gliomas.
Material and methods: Researched group included 26 patients who were treated on a complex of proton therapy Prometeus. 57.7 % of tumors were glioblastoma, 26.9 % – gliomas of GII and 15.4 % GIII gliomas. Proton therapy was carried out with use of the active scanning beam, image-guiding system and use of the individual fixing devices. To all patients PET/CT with 11С-methionine and MRI were carried out, target volume delineation was carried out by results of coregistration of both images.
Results: Terms of observation were from 1 to 32 months. The assessment of direct efficiency is carried out at 19 patients in 3 months after completion of treatment. From the group 52.7 % of patients (n = 10) had disease stabilization. At 11.5 % (n = 3) – partial response. Tumor regression volume varied from 50 to 90 %. Progressing of a disease developed in 31.5 % of the considered cases (n = 6). Other 7 patients expect control inspection. 15.4 % (n = 4) patients developed grade 2 radiodermatitis in the field of radiation fields, the remaining 84.6 % (n = 22) had grade 1 radiodermatitis. Of the entire group of patients, only one case of the development of a late radiation complication in the form of radionecrosis is observed at an observation period of 13 months.
Conclusion: Preliminary results of a research showed that performing proton therapy by the active scanning beam is the effective method of treatment of patients with the diagnosed recurrent gliomas, allowing to increase life expectancy of patients with maintaining satisfactory general condition.
Key words: proton therapy, gliomas, recurrent, reirradiation, radiation complications
REFERENCES
1. Desjardins A, Gromeier M, Herndon JE, Beaubier N, Bolognesi DP, Friedman AH, et al. Recurrent glioblastoma treated with recombinant poliovirus. New Engl J Med. 2018;379(2):150-61.
2. Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1350-60.
3. Langedijk JA. Re-irradiation: new frontiers. Springer, 2011. P. 85-93.
4. NCCN Clinical practice guidelines in oncology. Central nervous system. Version 1.2018. National Comprehensive Cancer Network. 2018.
10. Fogh SE, Andrews DW, Glass J, Curran W, Glass C, Champ C, et al. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol. 2010 Jun 20;28(18):3048-53. DOI: 10.1200/JCO.2009.25.6941.
11. Kong DS, Lee JI, Park K, Kim JH, Lim DH, Nam DH. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas. Cancer. 2008 May 1;112(9):2046-51. DOI: 10.1002/ cncr.23402.
5. Klimanov VA, Zabelin MV, Galyautdinova ZhZh. Proton radiation therapy: current state and prospects. Medical Physics. 2017;2:89-96. (Russian).
6. Tsyb AF, Gulidov IA. The current state of radiation therapy of malignant neoplasms. In: Therapeutic Radiologija GEOTAR Publ, 2013. P. 7-12. (Russian).
7. Gulidov IA, Gordon KB, Balakin VE, Galkin VN, Gogolin DV, Kaprin AD, et al. New possibilities for proton therapy in Russia. Problems in Oncology. 2016;62(5):570-2. (Russian).
9. Kohshi K, Yamamoto H, Nakahara A, Katoh T, Takagi M. Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas. J Neurooncol. 2007 May;82(3):297-303.
13. Ang KK, Jiang GL, Feng Y, Stephens LC, Tucker SL, Price RE. Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):1013-20.
8. Kobyakov GL, Smolin AV, Bekyashev AKh, Absalyamova OV, Kobyakova EA, Poddubsky AA, Inozemtseva MV. Treatment for recurrent glioblastoma: are there successes? Head and Neck Tumors. 2014.36:12-21. (Russian).
12. Galle J, McDonald M, Simoneaux V, Buchsbaum JC. Reirradiation with proton therapy for recurrent gliomas. Int J Particle Ther. 2015;2(1):11-8.
14. Leonie M, Harald O, Gudrun I. Basics of radiation protection for everyday use: how to achieve ALARA: working tips and guidelines. Geneva: World Health Organization. 2004: 83.
15. Kaprin AD, Galkin VN, Zhavoronkov LP, Ivanov VK, et al. Synthesis of fundamental and applied research in the basis for ensuring a high level of scientific results and their introduction into medical practice. Radiation and Risk. 2017;26(2):26-40. (Russian).
For citation: Medvedeva KE, Gulidov IA, Mardynski YuS, Gogolin DV, Gordon KB, Semenov AV, Lepilina OG, Kaprin AD, Kostin АА, Ivanov SA. Proton Therapy for Re-Irradiation of Recurrent Gliomas. Medical Radiology and Radiation Safety. 2019;64(2):70-4. (Russian).
PDF (RUS) Full-text article (in Russian)